NCT05006664 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05006664
Title	Brentuximab Vedotin in Combination With CHEP in Patient With PTCL
Recruitment	Unknown status
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Czech Lymphoma Study Group
Indications	anaplastic large cell lymphoma angioimmunoblastic T-cell lymphoma hepatosplenic T-cell lymphoma adult T-cell leukemia/lymphoma peripheral T-cell lymphoma
Therapies	Brentuximab vedotin + Cyclophosphamide + Doxorubicin + Etoposide + Prednisone
Age Groups:	adult \| senior
Covered Countries	CZE

NCT05006664
Clinical Trial Detail